Based on bioinformatics analysis, we could speculate that GSN played a favourable role in prognosis of RCC patients, and RCC patients with high GSN expression would probably respond to immunotherapy due to well cytotoxicity of CD8+ T cells. The gene discussed is CD8A; the disease is renal cell carcinoma.